Final Adult Height in Children with Congenital Adrenal Hyperplasia Treated with Growth Hormone
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
CONTEXT: Patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency typically reach a final adult height well below their mid-parental target height. OBJECTIVE: The objective of this study was to examine whether GH alone or in combination with an LHRH analog (LHRHa) improved the final adult height in patients with CAH. DESIGN: The study was a nonrandomized prospective study. SETTING: The study was conducted at two university hospitals in New York City, NY. PARTICIPANTS: Thirty-four patients with CAH treated with GH participated in this study. Nineteen males and 15 females who were predicted to be more than 2 SD below their mid-parental target height or more than 2 SD below the population mean received GH until reaching final adult height. In addition to GH, 27 patients (16 males, 11 females) were also treated with an LHRHa. INTERVENTION: The mean duration of GH treatment was 5.6 ± 1.8 yr in males and 4.5 ± 1.6 yr in females. The mean duration of LHRHa therapy was 3.7 ± 1.7 yr for both sexes. MAIN OUTCOME MEASURES: The primary endpoint variables were final adult height, final height discrepancy, and gain in height. RESULTS: Males reached a significantly higher final adult height (172.0 ± 4.8 cm) than their initial predicted height (162.8 ± 7.7 cm) (P < 0.00001). Females also reached a significantly higher final adult height (162.2 ± 5.3 cm) than initially predicted (151.7 ± 5.2 cm) (P < 0.0000001). Mean gain in height was 9.2 ± 6.7 cm in males and 10.5 ± 3.7 cm in females. CONCLUSION: Our results indicate that GH alone or in combination with LHRHa improves final adult height in patients with CAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Children with classic CAH (n = 20) with predicted adult height two standard deviations below their MPH treated with GH alone or in combination with a GnRH analogue achieved taller adult height compared with their predicted height at baseline (mean age at study entry: 8.6 years)79,80.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Overall, however, data on the benefits of GH with or without a GnRH analogue are limited to small, non-randomized studies79,80, which limits the recommendation of such growth-promoting therapies in regular clinical practice24.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRIST
GREULICH, W. W., & PYLE, S. I. (1959) · The American Journal Of The Medical Sciences · doi:10.1097/00000441-195909000-00030 · Cited by 5,585
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 2×
“In the 2010 Endocrine Society CAH Clinical Practice Guideline, GH treatment was not recommended as standard treatment for CAH patients due to limited data on the subject (45).”
BackgroundMethodCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Bayley, N., & Pinneau, S. R. (1952) · The Journal of Pediatrics · doi:10.1016/s0022-3476(52)80205-7 · Cited by 1,196
Standards for Children's Height at Ages 2-9 Years Allowing for Height of Parents
Tanner, J. M., Goldstein, H., & Whitehouse, R. H. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.244.755 · Cited by 812
High frequency of nonclassical steroid 21-hydroxylase deficiency
SPEISER, P. W., DUPONT, B. O., RUBINSTEIN, P., PIAZZA, A., KASTELAN, A., & NEW, M. I. (1986) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198604000-00017 · Cited by 523
Self-citationHigh frequency of nonclassical steroid 21-hydroxylase deficiency.
Speiser, P., Dupont, B., Rubinstein, P., Piazza, A., Kaštelan, A., & New, M. I. (1985) · PubMed · Cited by 374
Self-citationTanner, J. M., Whitehouse, R. H., Marshall, W. A., & Carter, B. S. (1975) · Archives of Disease in Childhood · doi:10.1136/adc.50.1.14 · Cited by 348
Nonclassical 21-Hydroxylase Deficiency
New, M. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1645 · Cited by 315
Self-citationLong Term Outcome in Adult Males with Classic Congenital Adrenal Hyperplasia1
Cabrera, M. S., Vogiatzi, M. G., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7668 · Cited by 204
Self-citationEugster, E. A., DiMeglio, L. A., Wright, J. C., Freidenberg, G. R., Seshadri, R., & Pescovitz, O. H. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.110527 · Cited by 197
Glucocorticoid Effects on Somatomedins and Somatomedin Inhibitors*
UNTERMAN, L. S., & PHILLIPS, S. L. S. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-4-618 · Cited by 189
Adult Height in Patients with Congenital Adrenal Hyperplasia: A Systematic Review and Metaanalysis
Muthusamy, K., Elamin, M. B., Smushkin, G., Murad, M. H., Lampropulos, J. F., Elamin, K. B., Abu Elnour, N. O., Gallegos-Orozco, J. F., Fatourechi, M. M., Agrwal, N., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2616 · Cited by 182
Klingensmith, G. J., Garcia, S. C., Jones, H. W., Migeon, C. J., & Blizzard, R. M. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80581-7 · Cited by 163
Jääskeläinen, J., & Voutilainen, R. (1997) · Pediatric Research · doi:10.1203/00006450-199701000-00005 · Cited by 160
Treatment of Glucocorticoid-Induced Growth Suppression with Growth Hormone
Allen, D. B., Julius, J. R., Breen, T. J., & Attie, K. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5036 · Cited by 153
Merke, D. P., Bornstein, S. R., Avila, N. A., & Chrousos, G. P. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00012 · Cited by 147
PESCOVITZ, O. H., COMITE, F., CASSORLA, F., DWYER, A. J., POTH, M. A., SPERLING, M. A., HENCH, K., McNEMAR, A., SKERDA, M., LORIAUX, D. L., et al. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-5-857 · Cited by 144
Girgis, R., & Winter, J. S. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4320 · Cited by 139
Lin-Su, K., Vogiatzi, M. G., Marshall, I., Harbison, M. D., Macapagal, M. C., Betensky, B., Tansil, S., & New, M. I. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2128 · Cited by 111
Self-citation(1988) · PubMed · Cited by 110
Balsamo, A., Cicognani, A., Baldazzi, L., Barbaro, M., Baronio, F., Gennari, M., Bal, M., Cassio, A., Kontaxaki, K., & Cacciari, E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030123 · Cited by 102
Pinto, G., Tardy, V., Trivin, C., Thalassinos, C., Lortat-Jacob, S., Nihoul-Fékété, C., Morel, Y., & Brauner, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021433 · Cited by 101
Manoli, I., Kanaka‐Gantenbein, C., Voutetakis, A., Maniati‐Christidi, M., & Dacou‐Voutetakis, C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01645.x · Cited by 100
Quintos, J. B. Q., Vogiatzi, M. G., Harbison, M. D., & New, M. I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7412 · Cited by 96
Self-citationInhibition by Prednisone of Growth Hormone (GH) Response to GH-Releasing Hormone in Normal Men
KAUFMANN, S., JONES, K. L., WEHRENBERG, W. B., & CULLER, F. L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-6-1258 · Cited by 87
Touati, G., Prieur, A. M., Ruiz, J. C., Noel, M., & Czernichow, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4569 · Cited by 85
The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH)
DiMartino-Nardi, J., Stoner, E., O'Connell, A., & New, M. I. (1986) · Acta Endocrinologica · doi:10.1530/acta.0.112s305 · Cited by 77
Self-citationHargitai, G., Sólyom, J., Battelino, T., Lebl, J., Pribilincová, Z., Hauspie, R., Kovács, J., Waldhauser, F., & Frisch, H. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049990 · Cited by 76
Growth and body proportions in congenital adrenal hyperplasia.
Young, M. C., Ribeiro, J., & Hughes, I. A. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.11.1554 · Cited by 55
Yu, A., & Grant, D. (1995) · Acta Paediatrica · doi:10.1111/j.1651-2227.1995.tb13789.x · Cited by 52
DACOU‐VOUTETAKIS, C., & KARIDIS, N. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb43873.x · Cited by 49 · cited 1×
“Additionally, central precocious puberty may develop in patients with CAH due to androgen activation of the hypothalamic-pituitary-gonadal axis, thus exacerbating premature epiphyseal fusion (29, 30).”
BackgroundAdrenal 21‐hydroxylase deficiency in childhood: 25 years' experience
LIM, Y. J., BATCH, J. A., & WARNE, G. L. (1995) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1995.tb00790.x · Cited by 43
Kohn, B., Julius, J. R., & Blethen, S. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.s5.1014 · Cited by 39
Evaluation of Young Women with Congenital Adrenal Hyperplasia: A Pilot Study
van der Kamp, H. J., Slijper, F. M. E., Brandenburg, H., Keizer-Schrama, D. M., Drop, S., & Molenaar, J. (1992) · Hormone Research · doi:10.1159/000182400 · Cited by 37
Combined Therapy with GnRH Analog Plus Growth Hormone in Central Precocious Puberty
Pucarelli, I., Segni, M., Ortore, M., Moretti, A., Iannaccone, R., & Pasquino, A. M. (2000) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2000.13.s1.811 · Cited by 34
[Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
David, M., Sempe, M., Blanc, M., Nicolino, M. P., Forest, M., & Morel, Y. (1994) · PubMed · Cited by 32
Growth Outcome during GnRH Agonist Treatments for Slowly Progressive Central Precocious Puberty
Massart, F., Federico, G., Harrell, J. C., et al. (2009) · Neuroendocrinology · doi:10.1159/000231994 · Cited by 30
Factors Determining Final Height in Congenital Adrenal Hyperplasia
New, M. I. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2001-s204 · Cited by 30
Self-citationNimkarn, S., New, M. I., & Lin-Su, K. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.8.883 · Cited by 29
Self-citationHauffa, B., Winter, A., & Stolecke, H. (1997) · Klinische Pädiatrie · doi:10.1055/s-2008-1043931 · Cited by 27
Brunelli, V., Russo, G., Bertelloni, S., Gargantini, L., Balducci, R., Chiesa, L., Livieri, C., De Sanctis, C., Einaudi, S., Virdis, R., et al. (2003) · PubMed · Cited by 26
Unresolved problems in the treatment of congenital adrenal hyperplasia.
Tanae, A., & Hibi, I. (1988) · PubMed · Cited by 13
Volta, C., Regazzi, C., Ndaka, J., Vitale, R., & Bernasconi, S. (2005) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 11
Research works printed but not linked: 2
- [1]1. New MI, Gertner JM, Speiser PW, Del Balzo P. 1989. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J Endocrinol Invest 12(Suppl 3):91–95 [PubMed] [Google Scholar]
- [2]2. Blizzard R. 1999. Adult consequences of pediatric endocrine disease: congenital adrenal hyperplasia. Growth Genet Horm 15:35–41 [Google Scholar]
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Han, T. S., Conway, G. S., Willis, D. S., Krone, N., Rees, D. A., Stimson, R. H., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), T. U. K. C. A. H. A. S. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1486 · Cited by 65
Rangaswamaiah, S., Gangathimmaiah, V., Nordenstrom, A., & Falhammar, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00493 · Cited by 59
Güven, A., Cebeci, A. N., & Hancili, S. (2015) · HORMONES · doi:10.14310/horm.2002.1555 · Cited by 39
Metadata
- Authors
- Lin-Su, K., Harbison, M. D., Lekarev, O., Vogiatzi, M. G., & New, M. I.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Cornell University (US)
- Corresponding author
- New, Maria I.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1710-1717
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC3206397
- OpenAlex
- W2126701770
- Cited by
- 75
- References
- 44
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 2
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (06020)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD000072, HD 00072, Z01HD000072)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, growth hormone therapy, GnRH analogues, adult height, short stature, height gain, sex differences
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Body Height, Child, Female, Humans, Gonadotropin-Releasing Hormone, Male, Prospective Studies, Treatment Outcome, Patient Selection, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.